Completed PHASE2 INTERVENTIONAL 4-arm NCT01680419

Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families

Sponsor: Collinge and Associates, Inc.

Conditions Compassion Depression PTSD Sleep Stress

Updated 5 times since 2017 Last updated: Jul 31, 2015 Started: Sep 30, 2012 Primary completion: May 31, 2015 Completion: May 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01680419, this PHASE2 trial focuses on Compassion and Depression and remains completed. Sponsored by Collinge and Associates, Inc., it has been updated 5 times since 2012, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Collinge and Associates, Inc.

Data source: Collinge and Associates, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.